On The Fly: Analyst Upgrade Summary Today's noteworthy upgrades include: Best Buy (BBY) upgraded to Buy from Neutral at Citigroup... Cabot Oil & Gas (COG) upgraded to Outperform from Market Perform at Bernstein... Green Plains (GPRE) upgraded to Overweight from Neutral at Piper Jaffray... Layne Christensen (LAYN) upgraded to Neutral from Sell at UBS... Mobile TeleSystems (MBT) upgraded to Equal Weight from Underweight at Barclays... ONEOK Partners (OKS) upgraded to Neutral from Sell at Goldman... Pearson (PSO) upgraded to Buy from Neutral at BofA/Merrill... priceline.com (PCLN) upgraded to Conviction Buy from Buy at Goldman... Lennar (LEN) upgraded to Strong Buy from Outperform at Raymond James... Saint Joe Co. (JOE) upgraded to Outperform from Market Perform at Raymond James... KB Home (KBH) upgraded to Market Perform from Underperform at Raymond James... D.R. Horton (DHI) upgraded to Market Perform from Underperform at Raymond James... Teva (TEVA) upgraded to Positive from Neutral at Susquehanna... Pacer (PACR) upgraded to Market Perform from Underperform at Raymond James.
Teva could merge with Mylan or Valeant, Bloomberg reports If Teva Pharmaceutical Industries (TEVA) canít restore value on its own and doesnít soon find a new CEO, a merger with generic drug makers Mylan (MYL) or Valeant Pharmaceuticals International. (VRX) appears likely, reports Bloomberg. Reference Link